MHC class II-associated invariant chain peptide replacement by T cell epitopes: Engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1524-1533

  Malcherek, Georg ^a,d   Wirblich, Christoph ^a   Willcox, Nicholas ^b   Rammensee, Hans Georg ^c   Trowsdale, John ^d   Melms, Arthur ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Interfakultares Inst F Z   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antigen presentation; Class II associated invariant chain peptide; Invariant chain hybrid; T cell epitope

Indexed keywords

CHLOROQUINE; CHOLINERGIC RECEPTOR; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; RECOMBINANT PROTEIN; TETANUS TOXIN;

ANTIGEN PRESENTATION; ARTICLE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR4 ANTIGEN; HUMANS; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN ENGINEERING; RECEPTORS, CHOLINERGIC; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TETANUS TOXIN;

EID: 0031897208     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199805)28:05<1524::AID-IMMU1524>3.0.CO;2-T     Document Type: Article

References (39)

1. Cresswell, P., Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 1994. 12: 259-293.
2. Germain, R. N., MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994. 76: 287-299.
3. Bijlmakers, M. J., Benaroch, P. and Ploegh, H. L., Mapping functional regions in the luminal domain of class II-associated invariant chain. J. Exp. Med. 1994. 180: 623-629.
4. Freisewinkel, I. M., Schneck, K. and Koch, N., The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 1993. 90: 9703-9706.
5. Romagnoli, P. and Germain, R. N., The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport and peptide occupancy. J. Exp. Med. 1994. 180: 1107-1113.
6. Teyton, L., O'Sullivan, D., Dickson, P. W., Lotteau, V., Sette, A., Fink, P. and Peterson, P. A., Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 1990. 348: 39-44.
7. Roche, P. A. and Cresswell, P., Invariant chain association with DR molecules inhibits immunogenic peptide binding. Nature 1990. 345: 615-618.
8. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S. L., Quranta, V. and Peterson, P. A., Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990. 348: 600-605.
9. Zhong, G., Castellino, F., Romagnoli, P. and Germain, R. N., Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 1996. 184: 2061-2066.
10. Bakke, O. and Dobberstein, B., MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990. 63: 707-716.
11. Bodmer, H., Viville, S., Benoist, C. and Mathis, D., Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 1994. 263: 1284-1286.
12. Denzin, L. K. and Cresswell, P., HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995. 82: 155-165.
13. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E. and Zaller, D. M., Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995. 375: 802-806.
14. Sherman, M. A., Weber, D. A. and Jensen, P. E., DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995. 3: 197-205.
15. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, A. A., Lane, W. S. and Strominger, J. L., Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993. 178: 27-47.
16. Max, H., Halder, T., Kropshofer, H., Kaibus, M., Muller, C. A. and Kalbacher, H., Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules. Hum. Immunol. 1993. 38: 193-200.
17. Riberdy, J. M., Newcomb, J. R., Surnam, M. J., Barbosa, J. A. and Cresswell, P., HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 1992. 360: 474-477.
18. Sette, A., Ceman, S., Kubo, R. T., Sakaguchi, K., Apella, E., Hunt, D. F., Davis, T. A., Michel, H., Shabanowitz, J., Rudersdorf, R., Grey, H. M. and DeMars, R., Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 1992. 258: 1801-1804.
19. Malcherek, G., Gnau, V., Jung, G., Rammensee, H.-G. and Melms, A., Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J. Exp. Med. 1995. 181: 527-536.
20. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D. C., The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995. 378: 457-462.
21. Wu, T.-C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T. and Pardoll, D. M., Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA 1995. 92: 11671-11675.
22. Sanderson, S., Frauwirth, K. and Shastri, N., Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc. Natl. Acad. Sci. USA 1995. 92: 7217-7221.
23. Nakano, N., Rooke, R., Benoist, C. and Mathis, D., Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science 1997. 275: 678-683.
24. Malcherek, G., Falk, K., Roetzschke, O., Rammensee, H.-G., Stevanovic, S., Gnau, V., Jung, G. and Melms, A., Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 1993. 5: 1229-1237.
25. Ong, B., Willcox, N., Wordsworth, P., Beeson, D., Vincent, A., Altmann, D., Lanchbury, J. S., Harcourt, G. C., Bell, J. I. and Newsom Davis, J., Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA 1991. 88: 7343-7347.
26. Larsen, S. L., Pedersen, L. O., Buus, S. and Stryhn, A., T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J. Exp. Med. 1996. 184: 183-189.
27. Nelson, C. A., Roof, R. W., McCourt, D. W. and Unanue, E. R., Identification of the naturally processed from of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc. Natl. Acad. Sci. USA 1992. 89: 7380-7383.
28. Vignali, D. A., Urban, R. G., Chicz, R. M. and Strominger, J. L., Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 1993. 23: 1602-1607.
29. Denzin, L. K., Robbins, N. F., Carboy-Newcomb, C. and Cresswell, P., Assembly and intracellular transport of HLA-DM and correction of the class II antigenprocessing defect in T2 cells. Immunity 1994. 1: 1-20.
30. Avva, R. R. and Cresswell, P., In vivo and in vito formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1994. 1: 763-774.
31. Sette, A., Southwood, S., Miller, J. and Appella, E., Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphisms in class II. J. Exp. Med. 1995. 181: 677-683.
32. van Ham, S. M., Grüneberg, U., Malcherek, G., Bröker, I., Melms, A. and Trowsdale, J., Human Histocompatibility Leukocyte Antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 1996. 184: 2019-2024.
33. Kropshofer, H., Arndt, S. O., Moldenhauer, G., Hämmerling, G. J. and Vogt, A. B., HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997. 6: 293-302.
34. Falk, K., Rötzschke, O., Stevanović, S., Jung, G. and Rammensee, H. G., Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics 1994. 39: 230-242.
35. Nelson, C. A., Vidavsky, I., Viner, N. J., Gross, M. L. and Unanue, E. R., Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 1997. 94: 628-633.
36. Jasanoff, A., Park, S. J. and Wiley, D. C., Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain. Proc. Natl. Acad. Sci. USA 1995. 92: 9900-9904.
37. Morkowski, S., Goldrath, A. W., Eastman, S., Ramachandra, L., Freed, D. C., Whiteley, P. and Rudensky, A. Y., T-cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Meet. 1995. 182: 1403-1413.
38. Strubin, M., Berte, C. and Mach, B., Alternative splicing and alternative initiation of translation explain the four forms of the la antigen-associated invariant chain. EMBO J. 1986. 5: 3483-3488.
39. Melms, A., Malcherek, G., Gern, U., Wietholter, H., Muller, C. A., Schoepfer, R. and Lindstrom, J., T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit. Ann. Neurol. 1992. 31: 311-318.